Pharmaceutical Research

  • Eurasian Patent - Drug Composition for Preventing Cannabis Relapse and Its Applications
    Eurasian Patent - Drug Composition for Preventing Cannabis Relapse and Its Applications

    The Eurasian Patent Office has authorized a patent, publication number RU202492842, for a pharmaceutical composition and its application for preventing the relapse of cannabis.

  • EU patent - a compound sustained-release combination of naltrexone and risperidone
    EU patent - a compound sustained-release combination of naltrexone and risperidone

    Authorized EU Patent, Publication No. EP20960660.7, a compound sustained-release combination of naltrexone and risperidone

  • Invention Patent - Implant Automatic Coating Device and Coating Process
    Invention Patent - Implant Automatic Coating Device and Coating Process

    Domestic authorized invention patent, patent number: 2018109614473, automatic encapsulation device and encapsulation process for implants

  • Invention Patent - Quantitative Extraction and Analysis Method of Trace Polyvinyl Alcohol in Polylactic Acid Microspheres
    Invention Patent - Quantitative Extraction and Analysis Method of Trace Polyvinyl Alcohol in Polylactic Acid Microspheres

    Authorized invention patent, application number: 2020112711476, a quantitative extraction and analysis method for trace polyvinyl alcohol in polylactic acid microspheres

  • US invention patent - Implant Coating And Drying Device
    US invention patent - Implant Coating And Drying Device

    US invention patent,Announcement No.US10702885B2,Implant Coating And Drying Device

  • US invention patent - Preparetion Method Of Naltrexone Implants
    US invention patent - Preparetion Method Of Naltrexone Implants

    US invention patent,Announcement No.US11197829B2,Preparetion Method Of Naltrexone Implants

  • Invention Patent - A Pharmaceutical Composition and Application for Relieving or Eliminating Opioid Withdrawal Syndrome
    Invention Patent - A Pharmaceutical Composition and Application for Relieving or Eliminating Opioid Withdrawal Syndrome

    Domestic invention patent, patent number: 2020114312165, a pharmaceutical composition and application for alleviating or eliminating opioid withdrawal syndrome

  • Invention Patent - Compound slow-release implant of naltrexone and risperidone, its preparation method and application
    Invention Patent - Compound slow-release implant of naltrexone and risperidone, its preparation method and application

    Domestic invention patent, patent number: 2022111955504, compound sustained-release implant of naltrexone and risperidone and its preparation method and application

  • Invention patent - A hydrochloride naltrexone pellet for treating tumors and its preparation method
    Invention patent - A hydrochloride naltrexone pellet for treating tumors and its preparation method

    Domestic invention patent, patent number: 2022103126415, a hydrochloride naltrexone pellet for treating tumors and its preparation method

  • Invention Patent - Aseptic Inspection Method and Aseptic Filtration Device for Insoluble Implants
    Invention Patent - Aseptic Inspection Method and Aseptic Filtration Device for Insoluble Implants

    Domestic invention patent, patent number: 202110642280.6, a sterile inspection method and sterile filtration device for insoluble implants

  • Invention Patent - An Implant Coating and Drying Device
    Invention Patent - An Implant Coating and Drying Device

    Authorized invention patent, application number: 2018109626470, for an implant capsule and drying device

  • Invention Patent - A sustained-release donepezil implant and its preparation method and use
    Invention Patent - A sustained-release donepezil implant and its preparation method and use

    Domestic authorized invention patent, patent number: 202211283427.8, a sustained-release donepezil implant and its preparation method and use

1